Voltas Limited, India’s leading air-conditioner brand and Ardutch B.V., a subsidiary of Arçelik, a leading player in the home appliances industry of Turkey, launched their brand - Voltas Beko. The brand will provide a wide range of home appliances which include Refrigerators, Washing Machines, Microwaves, and Dishwashers.

Sebi has changed the incentive structure of mutual fund distributors from the start of this financial year so that now the next set of cities could get the required attention.

The history of mutual funds in India is long, however, the growth in the size of assets is not commensurate to the period of existence of the mutual fund in India.

Government increased the price of ethanol by 25 per cent in order to incentivise sugar mills to utilise sugar cane juice for the production of ethanol. This will help reduce the formation of an expected sugar surplus this year.

The stocks most likely to experience significant movement on the bourses on September 14, 2018, are A2Z Infra Engineering, ITC and Godrej Consumer Products. The market will remain closed on September 13, 2018 on the occasion of Ganesh Chaturthi. 

Share price of KIOCL marked an 11 per cent intraday gain on Wednesday in anticipation of a potential buyback of shares on September 18, 2018. The decision will be taken on the same day after a meeting of the Board of Directors.

GIC Re has emerged as the 10th largest amongst the top 40 Global Reinsurers, as reported by Standard and Poor’s. The ranking is based on the net premium booked by the reinsurer in 2018. GIC Re demonstrated 24.5 per cent growth in its top line during FY 2018, while amassing a staggering premium of Rs. 41,799 crore.

The state-owned company's Initial Public Offering (IPO) of approx Rs. 1,350 crore will be issued at a price band of Rs. 115.00-118.00 per share.

The advantages of diversification is a much talked topic in the investor community. Diversification is one of the key tools for mitigating risk. Diversification means investing in unrelated asset classes. Investors may also further diversify their portfolio by spreading risk across geographies.

Health Ministry has prohibited the manufacture and sale of 328 fixed-dose combinations (FDCs) for human use with immediate effect observing that they may involve risk to patients.